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A B S T R A C T
Purpose: To deﬁne the prevalence and associations of co-morbidity and school attendance in older
children with epilepsy (CWE) from a rural district of Tanzania by conducting a community-based case–
control study.
Methods: Children aged 6–14 years old with active epilepsy (at least two unprovoked seizures in the last
ﬁve years) were identiﬁed in a cross-sectional survey in Tanzania. Co-morbidities were assessed and
cases were compared with age-matched controls.
Results: Co-morbidity was very common amongst cases (95/112, 85%), with 62/112 (55%) having
multiple co-morbidities. Co-morbidities consisted of cognitive impairment (72/112, 64%), behaviour
disorder 68/112 (61%), motor difﬁculties 29/112 (26%), burns and other previous injuries (29/112, 26%).
These complications were signiﬁcantly more common in cases than in controls (odds ratio 14.8, 95%CI
7.6–28.6, p < 0.001). Co-morbidity in CWE was associated with structural cause, abnormal
electroencephalogram and early onset seizures. Cognitive impairment was very common in CWE
(64%) and was not associated with Phenobarbital use but was associated with motor difﬁculties, early
onset and recurrent seizures. Poor school attendance was found in 56/112 (50%) of CWE, but not in the
controls: it was associated with the presence of multiple co-morbidities, especially with motor
difﬁculties in CWE.
Conclusion: Children with epilepsy in a rural area of sub-Saharan Africa had a high level of co-morbidity.
Cognitive impairment and poor school attendance were very common. These associated difﬁculties in
CWE in the region need to be addressed to reduce the negative impact of epilepsy on these children.
Crown Copyright 
 2011 British Epilepsy Association. Published by Elsevier Ltd. 
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The incidence of epilepsy is much higher in low and middle
income countries (LMICs) compared to high income countries
(HICs).1 In LMICs, the incidence of epilepsy is 100–190/100,000 per
year2 with the highest rates in children up to 18 years of age.3 It is
increasingly recognised that co-morbidities with epilepsy may* Corresponding author at: KCCO, PO Box 2254, KCMC, Moshi, Tanzania.
Tel.: +255 0765 730398.
E-mail address: kjburton@doctors.org.uk (K. Burton).
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doi:10.1016/j.seizure.2011.10.011form a large part of the burden of epilepsy. Co-morbidities (the
greater than coincidental association of two conditions in the same
individual) in children with epilepsy (CWE) are common in HICs.
They include disabling chronic conditions such as cognitive
impairment, neuropsychiatric conditions and motor problems.4
The impact of these co-morbidities can be lifelong and signiﬁcantly
affect psychosocial outcome5 and reduce quality of life for CWE.6
There are only a few, mostly observational, studies on co-
morbidities in CWE from LMIC.7–12 There have been no previous
community-based studies in sub-Saharan Africa (SSA) reporting on
factors associated with the common co-morbidities found in CWE.
Therefore we investigated the prevalence, type and associations ofr Ltd. Open access under CC BY license.
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survey in a rural part of Tanzania.
2. Materials and methods
2.1. Study area and population
We conducted a cross-sectional study of epilepsy in Hai district,
Northern Tanzania by identifying all 6–14 year old children with
epilepsy through a door-to-door survey. We used age-matched
controls selected from Hai for comparison as previously described
(Burton et al., in press).
2.2. Deﬁnitions
We used the International League Against Epilepsy (ILAE)
deﬁnitions and deﬁned active epilepsy as two or more afebrile
seizures, 24 h apart, unrelated to acute infection, metabolic
disturbance, neurological disorders or drugs, in the last ﬁve
years.13 Children who were on antiepileptic drugs were also
considered to have active epilepsy. Epileptic seizures were
classiﬁed according to the ILAE guidelines.14 The aetiology of
seizures was categorised as idiopathic or structural if there was
sufﬁcient evidence from history and examination to assess for an
underlying cause for epilepsy and as undetermined if there was
insufﬁcient data.15
2.3. Subject ascertainment and criteria for inclusion and exclusion
During a census in January 2009 a previously validated
questionnaire to identify epilepsy was administered to all house-
holds in Hai district16 and village enumerators were also trained to
identify likely cases of epilepsy. The study paediatrician (KJB), who
has training in paediatric epilepsy, assessed each child. The
diagnosis of active epilepsy and seizure type were veriﬁed by
paediatric neurologists (CN and BN). For this study, cases of
epilepsy were deﬁned as children with active epilepsy aged 6–14
years who were resident in Hai at the census. Those children for
whom consent was refused or who were below 6 years old (to
eliminate any children with febrile seizures) were excluded.
Controls were drawn from a random computer generated sample
selected from all the children aged 6–14 years who were resident
in Hai at the census in 2009. Controls were identiﬁed through the
census by matching for age (1 year), sex and village to the positive
responders. From this list of eligible children, we estimated that 186
controls were required to account for the likely 25% refusal rate, to
give at least one control for each case.
2.4. Neuropaediatric assessment
A full clinical history was taken using a standardised
questionnaire and a neuropaediatric examination was completed
for each case and control. All probable epilepsy cases and controls
were recalled for further assessment. For cases, clinical history and
response to treatment were reviewed.
An electroencephalogram (EEG) and computerised tomography
(CT) scan were offered to every case at recall. EEG was performed
using a Nihon Kohden (Japan) Neurofax 11000K machine. 20 leads
were attached using a standard montage. Patients had EEGs whilst
awake with hyperventilation and photic stimulation. Most
patients also had recordings whilst asleep, A UK neurophysiologist
(RW) reported EEGs using a standardised form. The CT scans were
performed with contrast on a Philips Tomoscan 4000 machine. CT
scans were reported locally to exclude acute pathology and were
then reported using a standardised format by a paediatric
neuroradiologist (KM) in the UK.An assessment of cognitive function was made using the
Goodenough–Harris Drawing Test.17 Those scoring less than 70
(>2 standard deviations below the mean) were categorised as
having cognitive impairment. The Goodenough–Harris Drawing
Test was used in this study to compare cognitive function as it has
been shown to have good reliability and validity compared to other
tests of intelligence.18,19
The Rutter questionnaire was used for assessing behaviour.20
Many of the cases did not attend school so the parent scale was
used to give a comparable score for all children. Children with total
scores of 13 or more were designated as showing behaviour
disorder.
History of injuries, motor and feeding difﬁculties were assessed
from the history and examination. A child was designated as
having feeding difﬁculties if they presented with at least one of the
following: coughing, choking or taking more than half an hour at
meal times. Any child who was not attending school regularly or
not at all was designated to have poor school attendance. We
measured Snellen visual acuity at six metres using letter matching
in each eye separately. A child was designated as having visual
impairment if visual acuity was less than 6/12 in either eye. We
assessed auditory discrimination from three metres behind the
subject.
3. Ethical approval
Approval for this study was obtained from the National
Institute for Medical Research in Tanzania and locally from the
Ethics Committee of Kilimanjaro Christian Medical College, Moshi.
Parents and guardians were given written and verbal information
in Kiswahili before signing consent forms agreeing to participation.
Children with conditions requiring treatment or referral were
referred appropriately to local services.
3.1. Data analysis
All data were double entered into a Microsoft Access (2007,
Microsoft Corporation, Redmond, WA) database. The two database
copies were compared using Epidata (Version 3.1, Epidata
Association, Denmark) and each discrepancy was checked against
original data forms. Statistical analysis was performed using STATA
v.10 (Statacorp, College Station, TX, USA).
Univariate odds ratios (OR) with 95% conﬁdence interval
(95%CI) were calculated for associations between epilepsy and
co-morbidity (comparing none to one or multiple co-morbidities
with burns and injuries excluded) using ordinal logistic regression.
Ethnic groups were classiﬁed as Chagga (the predominant group)
against the others. Education of head of household was a surrogate
marker for socio-economic status as previous research showed
that this was a key determinant in explaining the between-
household variation in expenditure.21 Early-onset epilepsy was
deﬁned as that which started at or before the age of three years.
Cases were labelled as having recurrent seizures if they had any
ongoing seizures in the three months before follow-up. Multivari-
able logistic regression models were developed for cases including
factors with p-values less than or equal to 0.2 in the univariate
analysis.
4. Results
4.1. Study subjects
Overall 112 children with active epilepsy and 113 controls were
identiﬁed (Supplementary Fig. 1). For one case only (girl, aged 10
years) carers refused consent. Demographic characteristics are
presented in Table 1; age, sex and head of the household education
Table 2
Co-morbidities in cases and controls.
Cases (N = 112) Controls
(N = 113)
N (%) N (%)
Fig. 1. Overlap of co-morbidities in children with epilepsy.
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controls. The proportion of cases from the Chagga ethnic group was
lower in cases than for controls (OR 2.5, 95%CI 1.2–5.3, p = 0.014),
mainly because of greater refusal in consent. However, those CWE
who were Chagga were not signiﬁcantly different to others in
terms of sex, age, education of household head or on seizure
variables. Cases were less likely to have both parents residing at
home. Of 186 computer selected potential matched controls, 73
(39%) were either not found or their carer refused consent. There
was no signiﬁcant difference between controls who were seen and
controls who were not in terms of age and sex (median age 11
years for both, t-test p = 0.39; and 52.2% and 46.6% were male,
respectively, OR 1.3, 95%CI 0.7–2.3, p = 0.45; other variables were
not available for analysis).Table 1
Characteristics of children with epilepsy and controls.
Characteristics Cases
(N = 112)
Controls
(N = 113)
Chi squared
N (%) N (%) p-Value
Sex
Male 57 (50.9) 57 (50.4) p = 0.946
Female 55 (49.1) 56 (49.6)
Age at assessment (years)
Less than 12 years 73 (65.2) 75 (66.4) p = 0.850
12 years and over 39 (34.8) 38 (33.6)
Ethnic group (Chagga)
Chagga 86 (76.8) 101 (89.4) p = 0.012
Other 26 (23.2) 12 (10.6)
Religion (Christian)
Christian 91 (81.3) 90 (79.7) p = 0.762
Muslim and other 21 (18.7) 23 (20.3)
Parents resident at home
Both 71 (63.4) 89 (78.8) p = 0.025
One parent 26 (23.2) 18 (15.9)
None 14 (12.5) 5 (4.4)
Not known 1 (0.9) 1 (0.9)
Education of head of house
None 6 (5.4) 3 (2.7) p = 0.196
Primary 93 (83.0) 90 (79.6)
Secondary 11 (9.8) 12 (10.6)
Not known 2 (1.8) 8 (7.1)In cases, the probable aetiology from the clinical history was
idiopathic in 56/112 (50.0%), hypoxic ischaemic encephalopathy in
10/112 (8.9%), intracranial infection in 9/112 (8.0%), head injury 3/
112 (2.7%), neurocutaneous disorder (one each of tuberous
sclerosis, neuroﬁbromatosis and Sturge–Weber) in 3/112 (2.7%),
other disorders in 19/112 (17.0%) and undetermined in 12/112
(10.7%). 13/112 (11.6%) had a positive family history of non-febrile
seizures. An episode of status was reported in 32/112 (28.6%), had
not occurred in 70 (62.5%) and was not known in 10 (8.9%). Onset of
seizures was before 6 years of age in 71/112 (63.4%).
4.2. Prevalence and types of co-morbidity
The prevalence of co-morbidity was high in CWE; 95 (84.8%) had
one or more co-morbidities compared to 31 (27.4%) controls (mostly
behavioural problems); 69 (61.6%) CWE had multiple comorbid
conditions compared to 4 (3.5%) of controls. Any or multiple co-
morbidities were signiﬁcantly more common in the cases than in the
controls; OR 14.8, 95%CI 7.6–28.6, p < 0.001. The range of co-
morbidities in cases and controls are shown in Table 2 and Fig. 1.
Motor difﬁculties were present in 29 (25.9%) CWE and of these,
19 (65.5%) had cerebral palsy. In those with motor difﬁculties, all
had multiple comorbid conditions and 14 (48.2%) had four or more
co-morbidities. In 10 (8.9%) cases there were feeding difﬁculties of
whom 9 had associated cerebral palsy and 1 had an unclassiﬁed
seizure disorder with regression. Disordered behaviour was found
in 66% of cases compared to 19% controls, the latter mostly had
mildly disordered behaviour (Burton et al., in press).
4.3. Associations with co-morbidity
The factors associated with co-morbidity in cases on univariate
analysis are shown in Table 3. On multivariable regressionCo-morbidity
None 17 (15.2) 82 (72.6)
One 26 (23.2) 27 (23.9)
Multiple 69 (61.6) 4 (3.5)
Type of co-morbidity
Motor difﬁculties present 29 (25.9) 0 (0)
No motor difﬁculties 83 (74.1) 113 (100)
Accidental burns and injuries 18 (16.1) 7 (6.2)
No other accidental injuries 94 (83.9) 106 (93.8)
Burns form seizures 11 (9.8) 0 (0)
Cognitive impairment
Present 72 (64.3) 6 (5.3)
None 30 (26.8) 93 (82.3)
Not known 10 (8.9) 14 (12.4)
Behavioural problems
Present 68 (60.7) 19 (16.8)
None 36 (32.1) 80 (70.8)
Not known 8 (7.2) 14 (12.4)
Hearing impairment
Present 0 (0.0) 1 (0.9)
None 100 (99.1) 112 (99.1)
Not known 1 (0.9) 0 (0)
Visual impairment
Present 11 (9.8) 2 (1.8)
None 100 (89.3) 111 (98.2)
Not known 1 (0.9) 0 (0)
Feeding problems
Present 10 (8.9) 0 (0)
None 101 (90.2) 113 (100)
Not known 1 (0.9) 0 (0)
Table 4
Factors associated with cognitive impairment in CWE.
Variable OR 95%CI p-Value
Univariate associations
Sex (male) 0.8 0.3–1.8 0.574
Age at assessment (years) 0.8 0.3–1.8 0.521
Ethnic group (not Chagga) 1.0 0.4–2.8 0.976
Parents resident at home
Both 1.0 – –
One 1.7 0.6–4.8 0.346
None 2.6 0.5–13 0.239
Education of head of house
(none/primary only)
2.6 0.7–9.9 0.150
Age at onset (3 years or less) 4.8 1.9–12 0.001
History of status (present) 1.6 0.6–4.5 0.381
Recurrent seizures (present) 2.5 1.0–6.1 0.044
More than one seizure type
(present)
2.5 0.5–12 0.248
Structural cause 2.3 0.9–5.9 0.076
Motor difﬁculties 17.4 2.2–135 0.006
Focal abnormalities on EEG
and/or CT scan
3.6 1.4–9.4 0.010
Treatment type
None 1.0 – –
Carbamazepine or Valproate 0.2 0.0–1.9 0.154
Phenobarbital 2.0 0.8–5.2 0.147
Polytherapy 3.8 0.4–33 0.226
Multivariable logistic regression model
Education of head of house
(none/primary only)
10.8 0.8–143.9 0.071
Age at onset (3 years or less) 6.4 1.9–21.4 0.003
Recurrent seizures (present) 4.2 1.2–14.7 0.023
Structural cause 0.8 0.2–3.2 0.707
Motor difﬁculties 20.3 1.2–331.7 0.035
Focal abnormalities on EEG
and/or CT scan
1.4 0.4–4.8 0.623
Treatment type
None 1.0 – –
Carbamazepine or Valproate 0.2 0.0–4.5 0.343
Phenobarbital 2.1 0.6–7.0 0.218
Polytherapy 2.7 0.2–31.0 0.434
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in CWE were structural aetiology, abnormal EEG and early onset of
seizures.
4.4. Prevalence and associations of cognitive impairment in cases
Cognitive impairment was very common in CWE and was
markedly more common in cases than in controls (72 (64.3%) in
cases vs 6 (5.3%) in controls; OR 37.2, 95%CI 14.7–94.2, p < 0.001).
Cognitive impairment was not associated with treatment type
(Table 4). The independent factors associated with cognitive
impairment in CWE in the multivariable model were motor
difﬁculties, early onset and recurrent seizures.
4.5. Prevalence and associations of school attendance
All the controls attended school regularly. However, 56/112
(50%) CWE were not attending school regularly. Of these, 52/56
(93%) had one or more co-morbidities compared to 41/54 (76%)
CWE who did attend school regularly (OR 4.1, 95%CI 1.3–13.6,
p = 0.020). CWE with co-morbidities were much less likely to
attend school (single OR 4.7, 95%CI 1.1–19.1, p = 0.033; multiple
OR 50.2, 95%CI 14.2–177, p < 0.001). Associations with poor school
attendance are shown in Table 5. As structural cause, early onset
and recurrent seizures were strongly associated with presence of
co-morbidity, they were excluded from the multivariable analysis.
In multivariable analysis the presence of multiple co-morbidities,
especially motor difﬁculties, and poor education of the household
head remained signiﬁcantly associated with poor school atten-
dance.
5. Discussion
Co-morbidities in CWE are increasingly recognised as an
important issue as they may adversely affect children even more
than the seizures themselves in terms of poor social long-term
outcome22 and reduced quality of life.6Table 3
Factors associated with co-morbidity (not including burns and injuries) in cases.
Variable OR 95%CI p-Value
Univariate associations
Sex (male) 1.0 0.5–2.0 0.935
Age at assessment (years) 0.4 0.2–0.9 0.027
Ethnic group (not Chagga) 0.9 0.4–2.1 0.798
Parents resident at home
Both 1.0 – –
One 1.6 0.7–3.0 0.311
None 1.5 0.5–4.4 0.498
Education of head of house
None 1.0 – –
Primary 0.3 0.03–2.6 0.265
Secondary 0.2 0.02–2.3 0.208
History of status (present) 0.7 0.3–1.6 0.385
Age at onset (3 years or less) 3.4 1.6–7.4 0.002
Recurrent seizures (present) 3.8 1.7–8.6 0.001
More than one seizure type (present) 2.0 0.6–6.9 0.255
Causal (structural) 5.3 2.2–12 <0.001
Abnormal EEG 4.7 2.0–11 <0.001
Abnormal CT scan 2.9 1.0–8.1 0.044
Multivariable logistic regression model
Age at assessment (years) 0.9 0.3–2.4 0.777
Age at onset (3 years or less) 3.1 1.2–8.5 0.024
Recurrent seizures (present) 2.5 0.9–7.0 0.094
Causal (structural) 4.5 1.4–12.6 0.013
Abnormal EEG 4.1 1.4–12.5 0.012
Abnormal CT scan 2.0 0.6–6.6 0.2775.1. Prevalence and types of co-morbidities in HICs and LMICs
There have only been a few community-based studies of the
prevalence and type of co-morbidities in CWE worldwide. The
largest study was a Finnish study of CWE5; behaviour problems
were found in 58%, communication difﬁculties in 78%, mobility
problems in 73% and learning difﬁculties were found in 76%.
Another Finnish population-based study of CWE found additional
neurological co-morbidity in 40% and learning difﬁculties in 31%.23
A population-based study from Canada reported that 21% of CWE
had mental retardation.24 The prevalence of co-morbidity in our
community-based study matched that from the largest study from
Finland but compared to the smaller studies, we found more
cognitive impairment amongst CWE and included other co-
morbidities such as behaviour disorder.
Few previous population studies from LMICs have studied the
prevalence and types of co-morbidity in CWE. A cross-sectional
survey from Kenya found 34/110 (31%) children with lifetime
epilepsy had moderate to severe neurological impairments, 22
(20%) had cognitive impairment and 5 (5%) motor impairment.11 In
a separate study of Kenyan adults and children with active
convulsive epilepsy, 27% had cognitive impairment.12 In our study,
the prevalence of any co-morbidity was higher; this is because in
our study, behaviour disorder and feeding difﬁculties were also
included and cognitive and motor difﬁculties were more common.
Reported rates of co-morbidities in CWE in studies from SSA may
be a relative underestimate compared to HICs. Children in SSA with
severe neurological impairments tend not survive, as shown in
Kenya where they found an increased mortality rate in children
Table 5
Factors associated with poor school attendance in cases.
Variable OR 95%CI p-Value
Univariate associations
Sex (male) 1.8 0.8–3.8 0.130
Age at assessment (years) 1.1 0.5–2.4 0.793
Ethnic group (not Chagga) 1.1 0.4–2.6 0.901
Parents resident at home
Both 1.0 – –
One 1.2 0.5–3.0 0.677
None 2.0 0.6–6.6 0.247
Education of head of house
(none/primary only)
3.1 0.8–12.3 0.111
Age at onset (3 years or less) 2.3 1.1–5.1 0.033
Co-morbidity
None 1.0 – –
One 1.1 0.3–3.7 0.978
Multiple 6.7 2.1–21.3 0.001
Recurrent seizures (present) 4.4 1.9–10.0 0.001
Structural 2.4 1.1–5.4 0.029
Motor difﬁculties 4.0 1.5–10.5 0.004
Behaviour disorder 1.0 1.0–1.1 0.110
Hearing or visual difﬁculties 1.8 0.5–6.6 0.362
Cognitive impairment 26.4 5.8–120.7 <0.001
Multivariable logistic regression model
Sex (male) 2.1 0.9–5.1 0.104
Education of head of house
(none/primary only)
3.0 0.7–14.1 0.158
Co-morbidity
None 1.0 – –
One 1.5 0.4–6.0 0.595
Multiple 10.2 2.8–37 <0.001
Multivariable logistic regression model using individual co-morbidity
typesa
Sex (male) 1.5 0.6–3.4 0.393
Education of head of house
(none/primary only)
7.2 1.4–38 0.020
Motor difﬁculties 7.1 2.1–23.5 0.001
Behaviour disorder 1.0 1.0–1.03 0.095
Hearing or visual difﬁculties 1.8 0.4–7.2 0.425
a In this analysis, binary variables for each of motor difﬁculty, behaviour disorder
and hearing/visual difﬁculty were inserted in the model to see their individual
associations with poor school attendance.
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ences between studies may also be due to variations in
populations, deﬁnitions and assessment tools.
5.2. Associations of co-morbidity in CWE
Comorbid conditions are likely to be caused by underlying brain
disorder. The evidence for this is from studies that show that
cognitive impairment,26 Attention Deﬁcit Hyperactivity Disorder27
and other behavioural problems28 predate the onset of seizures in
children. Our study design was not able to distinguish if co-
morbidities pre- or postdated the onset of epilepsy. Symptomatic
aetiology, abnormal EEG and early-onset seizures were associated
with co-morbidities in our study. They are all more likely to be seen
with underlying brain disorder and thus with co-morbidities.
5.3. Prevalence of cognitive impairment in HICs and LMICs
In HICs the reported prevalence of cognitive impairment in
CWE ranges from 31 to 76%.5,29–31 Our study found that cognitive
impairment was common (64%) matching the higher recorded
prevalences in HICs.
There are only two previous studies reporting on cognitive
function in CWE in sub-Saharan Africa, both from Kenya. A study of
children with active convulsive epilepsy, found that moderate to
severe cognitive impairment (assessed clinically) was present in
27%.12 The other cross-sectional study of children with lifetime
epilepsy, found 20% had cognitive impairment.11 In these studies,children with mild to moderate cognitive impairment may not
have been identiﬁed and in the second, were not included. This
together with different assessment tools and population char-
acteristics may account for the lower reported rate of cognitive
impairment compared to our study.
5.4. Associations of cognitive impairment in CWE
Multiple factors may account for the strong association
between cognitive impairment and epilepsy in our study.
Cognitive impairment may be part of the underlying brain
disorder, in some cases cognitive impairment may be made worse
by seizure activity or it could be related to antiepileptic drug use.
There is good evidence that cognitive impairment is part of the
underlying brain disorder in CWE. It has been shown that cognitive
impairment and cerebral palsy, which are both seen with brain
disorders, are associated with an increased risk of developing
epilepsy.32,33 In new-onset epilepsy, cognitive impairment has
been shown to pre-date seizure onset.34 Cognitive impairment can
also be made worse by abnormal electrical brain activity.35
Patients in whom seizures are refractory36 and with some
syndromes, can have cognitive decline.37
Most children were treated in our study, but those that were on
AED, were taking Phenobarbital (PB), which could be postulated as
the cause for the high prevalence of cognitive impairment. Early
studies found a worrying association between Phenobarbital use
for febrile seizure prophylaxis and cognitive problems but more
recent masked trials have shown no adverse effect on cognition in
children with epilepsy.38 There was no signiﬁcant association
between type of treatment and cognitive impairment in our study
and PB did not seem to have a signiﬁcant detrimental effect on
cognition in these CWE.
The association in our study between cognitive impairment and
epilepsy is likely to be multifactorial. Cognitive impairment was
associated with motor difﬁculties, early onset and recurrent
seizures. These are more likely to be found with underlying brain
disorder and therefore with cognitive impairment which concurs
with previous studies. Further studies on the nature and associations
of cognitive impairment in CWE in SSA would be helpful.
5.5. Impact of co-morbidity
Co-morbidities have been found to have a major impact on CWE
in terms of quality of life. Studies have found that neurological co-
morbidities had an adverse impact on health-related quality of
life.6,39 Co-morbidities have also been shown to have an adverse
effect on the lifelong social outcomes for CWE even if seizures
remit.22 Studies from across the world have shown that those with
childhood epilepsy received less education and were less likely to
be employed or married especially if they had associated cognitive
impairment.40–42 These studies concur with our study that found
that school attendance was poor in CWE, but not in controls and
was associated with the presence of co-morbidity particularly with
motor difﬁculties and to some extent with behaviour difﬁculties.
The effect on access to school of less education of the household
head may be causal in terms of income or of value placed on
accessing education. Access to specialist education for children
with cognitive impairment is very limited in Tanzania as teachers
are not able to meet special needs in mainstream schools, there are
only a few special schools and most of these are in urban areas.
5.6. Sources of bias
To minimise ascertainment bias in this community-based study
we aimed to identify all cases of epilepsy in children aged 6–14 years
in the study area by using a validated screening questionnaire and
K. Burton et al. / Seizure 21 (2012) 169–174174trained enumerators. Case status was deﬁned by two paediatric
neurologists. If children were unavailable initially, repeat visits
and transport to assessment were offered. Controls were well
matched in terms of age, sex and socioeconomic status and came
from the same population. Cases were less likely to have both
parents at home but this was probably because parents tended to
leave children with disabilities with relatives. More cases were
from non-Chagga groups compared to controls but did not differ
on the main variables from cases from the Chagga group. Genetic
or lifestyle differences may have had a small effect on the presence
of co-morbidities but similar ethnic groups were represented in
both cases and controls. Although the control group was randomly
chosen, it may not have been entirely representative of the general
population as there were more refusals amongst the potential
controls in the non-Chagga ethnic groups. However follow up rate
was high and drop-out rate was similar in both cases (7.1%) and
controls (11.5%). Both cases and controls were assessed using
identical methods and questionnaires. The assessors could not be
blinded to case status but were unaware of seizure variables and
assessment scores.
6. Conclusion
Children with epilepsy in a rural area of sub-Saharan Africa had
a very high level of co-morbidity, many with multiple co-
morbidities, particularly cognitive impairment and poor school
attendance. These associated difﬁculties in CWE in the region need
to be addressed to reduce the negative impact of epilepsy on the
life chances of these children.
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